Suchen Sie nach Informationen zu Hauptsitz Der Mannkind Corporation? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


MannKind Corporation - Wikipedia

    https://en.wikipedia.org/wiki/MannKind_Corporation
    none

MannKind Corporation - Life more humann

    https://mannkindcorp.com/
    SM. More carefree moments with family and friends. More health, more happiness, more freedom. At MannKind, we don’t just want to help people manage serious medical conditions – we want to help them experience the very best life has to offer. With our innovative Technosphere ® inhalation technology, our team of dedicated scientists and ...

MannKind Corporation Relocates Headquarters to …

    https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-relocates-headquarters-westlake-village
    WESTLAKE VILLAGE, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today the company has fully relocated its corporate headquarters to a 12,596-square-foot location in the Westlake Landmark office park in Westlake Village, California. A photo accompanying this announcement is available at http ...

Investor Home | MannKind Corporation

    https://investors.mannkindcorp.com/investor-relations
    To contact MannKind’s Investor Relations, please fill out the online information request form or e-mail: [email protected]. Where is MannKind located? 1 Casper Street. Danbury, CT 06810. 203.798.8000. 30930 Russell Ranch Road, Suite 300. Westlake Village, CA 91362. 818.661.5000. Who is your transfer agent?

MannKind Corporation | Encyclopedia.com

    https://www.encyclopedia.com/books/politics-and-business-magazines/mannkind-corporation
    MannKind Corporation. MannKind Corporation is a biopharmaceutical company committed to developing therapeutic products to treat diabetes, cancer, inflammatory, and autoimmune diseases. The first product expected to reach the market is the company ’ s Technosphere Insulin System, which consists of a proprietary dry-powder formulation of ...

Careers - MannKind Corporation

    https://mannkindcorp.com/careers/
    Helping humanns thrive. MannKind Corporation is looking for people who are driven to find new ways of changing lives for the better. Our team is energized by the company’s entrepreneurial spirit that provides an environment in which you can evolve ideas quickly and nimbly. The MannKind culture is shaped by individuals who believe in winning ...

Working at MannKind Corporation - Glassdoor

    https://www.glassdoor.com/Overview/Working-at-MannKind-Corporation-EI_IE35192.11,31.htm
    Industry: Biotech & Pharmaceuticals. Revenue: $10 to $25 million (USD) Competitors: Eli Lilly and Company, Medtronic, Novo Nordisk. Create Comparison. MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.

MannKind Corporation (MNKD) Stock Price, Quote

    https://stockanalysis.com/stocks/mnkd/
    MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric ...

MannKind Corporation Announces Agreement to Acquire …

    https://www.globenewswire.com/news-release/2022/05/17/2444674/0/en/MannKind-Corporation-Announces-Agreement-to-Acquire-V-Go-Insulin-Delivery-Device-From-Zealand-Pharma.html
    About MannKind Corporation MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases.

MannKind Corporation (MNKD) market price of $3.77 ... - Invest …

    https://investchronicle.com/2022/05/23/mannkind-corporation-mnkd-market-price-of-3-77-offers-the-impression-of-an-exciting-value-play/
    For the readers interested in the stock health of MannKind Corporation (MNKD). It is currently valued at $3.77. When the transactions were called off in the previous session, Stock hit the highs of $3.71, after setting-off with the price of $3.55. Company’s stock value dipped to $3.39 during the t

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Der Mannkind Corporation gefunden haben.